Wei Chen

A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial

Zhiling Yan, Jiang Cao, Hai Cheng et al. · The Lancet Haematology · 2019 · 310 citations

Hematological Malignancy, Medicine, Immunology +9

Potent anti‐leukemia activities of humanized CD19‐targeted Chimeric antigen receptor T (CAR‐T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

Jiang Cao, Gang Wang, Hai Cheng et al. · American Journal of Hematology · 2018 · 170 citations · Full text

Determining the Patient Acceptable Symptomatic State for the ASES, SST, and VAS Pain After Total Shoulder Arthroplasty

Aaron M. Chamberlain, Man Hung, Wei Chen et al. · Journal of Shoulder and Elbow Arthroplasty · 2017 · 46 citations · Full text

Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial

Dian Zhou, Qian Sun, Jieyun Xia et al. · The Lancet Haematology · 2024 · 42 citations

Hematological Malignancy, Cancer Immunosurveillance, Medicine +7

An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective Study

Kunming Qi, Zhiling Yan, Hai Cheng et al. · Frontiers in Oncology · 2021 · 40 citations · Full text